We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
-8.14%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$3.56B
AUM Growth
-$1.36B
Cap. Flow
-$1.11B
Cap. Flow %
-31.07%
Top 10 Hldgs %
29.11%
Holding
1,521
New
512
Increased
155
Reduced
168
Closed
620

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$193M
2
AMZN icon
Amazon
AMZN
+$126M
3
AMD icon
Advanced Micro Devices
AMD
+$77.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$49.2M
5
XYZ
Block Inc
XYZ
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 2.48%
2 Consumer Discretionary 1.2%
3 Communication Services 1.16%
4 Technology 1.08%
5 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
201
CALL
Visa
V
$701B
$3.37M 0.09%
+15,200
New +$3.29M
UAL icon
202
PUT
United Airlines
UAL
$38.8B
$3.31M 0.09%
+71,400
New +$3.1M
SLB icon
203
CALL
SLB Ltd
SLB
$72.7B
$3.31M 0.09%
80,000
+35,000
+78% +$1.37M
TUR icon
204
PUT
iShares MSCI Turkey ETF
TUR
$201M
$3.3M 0.09%
159,500
-136,000
-46% -$2.68M
WEN icon
205
PUT
Wendy's
WEN
$1.46B
$3.3M 0.09%
+150,000
New +$3.38M
JCI icon
206
CALL
Johnson Controls International
JCI
$85.1B
$3.28M 0.09%
50,000
-35,000
-41% -$2.41M
BNTX icon
207
BioNTech
BNTX
$23.5B
$3.24M 0.09%
+19,000
New +$3.19M
LOVE icon
208
PUT
LoveSac
LOVE
$242M
$3.23M 0.09%
+59,700
New +$2.86M
AES icon
209
AES
AES
$10.6B
$3.22M 0.09%
125,000
+110,000
+733% +$2.49M
GCO icon
210
CALL
Genesco
GCO
$434M
$3.18M 0.09%
+50,000
New +$3.25M
BIIB icon
211
Biogen
BIIB
$30.9B
$3.16M 0.09%
15,000
+8,500
+131% +$1.85M
C icon
212
Citigroup
C
$213B
$3.15M 0.09%
+59,000
New +$3.64M
KO icon
213
CALL
Coca-Cola
KO
$383B
$3.14M 0.09%
50,700
-184,300
-78% -$11.2M
KO icon
214
PUT
Coca-Cola
KO
$383B
$3.1M 0.09%
+50,000
New +$3.04M
CLX icon
215
PUT
Clorox
CLX
$12B
$3.07M 0.09%
+22,100
New +$3.39M
SNOW icon
216
CALL
Snowflake
SNOW
$98.1B
$3.05M 0.09%
+13,300
New +$3.44M
LYEL icon
217
CALL
Lyell Immunopharma
LYEL
$318M
$3.03M 0.09%
+30,000
New +$3.63M
CACC icon
218
CALL
Credit Acceptance
CACC
$5.82B
$3.03M 0.09%
5,500
NDAQ icon
219
CALL
Nasdaq
NDAQ
$53.4B
$3.01M 0.08%
+50,700
New +$3M
ZEN
220
PUT
DELISTED
ZENDESK INC
ZEN
$3.01M 0.08%
25,000
+12,700
+103% +$1.38M
NMM icon
221
CALL
Navios Maritime Partners
NMM
$2.22B
$2.99M 0.08%
+85,000
New +$2.57M
GNRC icon
222
PUT
Generac Holdings
GNRC
$11.5B
$2.97M 0.08%
+10,000
New +$3M
SPLK
223
CALL
DELISTED
Splunk Inc
SPLK
$2.97M 0.08%
20,000
-10,000
-33% -$1.22M
BTWN
224
CALL
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$2.95M 0.08%
299,100
STOK icon
225
CALL
Stoke Therapeutics
STOK
$1.84B
$2.95M 0.08%
+140,000
New +$2.8M

Similar funds

SG3 Management's Q1 2022 Portfolio in Review

As of Q1 2022, SG3 Management held 1,521 positions worth $3.56B, down 28% from $4.92B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

SG3 Management withdrew a net $1.11B in Q1 2022, closing 620 positions and reducing 168 holdings. Its most notable exit was Tesla, an estimated $193M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, up from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, SG3 Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $13.5M.

  • SG3 Management's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 30,000 shares worth $13.5M.
  • SG3 Management added most to Bausch Health in Q1 2022, an estimated $27.4M increase.
  • SG3 Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $126M.
  • SG3 Management fully exited Tesla in Q1 2022, selling an estimated $193M.
  • SG3 Management's ten largest holdings make up 29% of its $3.56B portfolio in Q1 2022.
  • SG3 Management opened 512 new positions and closed 620 in Q1 2022.
  • SG3 Management's portfolio value fell 28% quarter-over-quarter to $3.56B.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.